José Ángel Palomeque

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Transcription factors (TFs) are often considered undruggable due to their structural complexity. mRNA technologies can overcome this therapeutic limitation by enabling dynamic protein replacement therapies. Here, we explore the TF activity of LCOR (Ligand‐dependent corepressor),...